Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy von Schiffmann, Raphael, Warnock, David G., Banikazemi, Maryam, Bultas, Jan, Linthorst, Gabor E., Packman, Seymour, Sorensen, Sven Asger, Wilcox, William R., Desnick, Robert J.

Volltext

A New Strategy for the Treatment of Atherothrombosis – Inhibition of Inflammation von SLÍVA, J., CHARALAMBOUS, C., BULTAS, J., KARETOVÁ, D.

Volltext

A nationwide blood spot screening study for Fabry disease in the Czech Republic haemodialysis patient population von Merta, Miroslav, Reiterova, Jana, Ledvinova, Jana, Poupětová, Helena, Dobrovolný, Robert, Ryšavá, Romana, Maixnerová, Dita, Bultas, Jan, Motáň, Jiří, Slivkova, Jitka, Sobotova, Doris, Smrzova, Jana, Tesař, Vladimir

Volltext

New insights in cardiac structural changes in patients with Fabry’s disease von Linhart, Aleš, Paleček, Tomáš, Bultas, Jan, Ferguson, James J., Hrudová, Jana, Karetová, Debora, Zeman, Jiři, Ledvinová, Jana, Poupětová, Helena, Elleder, Milan, Aschermann, Michael

Volltext

Natural history of the respiratory involvement in Anderson-Fabry disease von Magage, S, Lubanda, J.-C, Susa, Z, Bultas, J, Karetová, D, Dobrovolný, R, Hřebíček, M, Germain, D. P, Linhart, A

Volltext

Cardiac manifestations in Fabry disease von Linhart, A., Lubanda, J.‐C., Palecek, T., Bultas, J., Karetová, D., Ledvinová, J., Elleder, M., Aschermann, M.

Volltext

Cardiac involvement in Fabry disease von Linhart, A, Magage, S, Palecek, T, Bultas, J

Volltext

Intravascular ultrasound assessment of coronary artery involvement in Fabry disease von Kovarnik, T, Mintz, G. S, Karetova, D, Horak, J, Bultas, J, Skulec, R, Skalicka, H, Aschermann, M, Elleder, M, Linhart, A

Volltext

Fabry disease: Vascular manifestations von KARETOVA, D, BULTAS, J, DOSTALOVA, G, PALECEK, T, KOVARNIK, T, GOLAN, L, LINHART, A

Volltext

Primary prevention of coronary artery disease among middle aged men in Prague: Twenty-year follow-up results von Boudík, F., Reissigová, J., Hrach, K., Tomečková, M., Bultas, J., Anger, Z., Aschermann, M., Zvárová, J.

Volltext

62 Alternative dosing regimens of agalsidase alfa (Replagal ®) in Fabry disease von Clarke, Joseph, West, M., Bultas, J., Askari, M., Schiffmann, R.

Volltext

Cardiac involvement in fabry disease:About numbers and notions von Strotmann, J, Pinderski, L, Bultas, J, Wanne, C, Weidemann, F

Volltext

Progression of left ventricularhypertrophy in fabry disease is faster in patients with phosphocreatine depletion: A phosphorus-31 magnetic resonance spectroscopy study von Bultas, J, Palecek, T, Dostalova, G, Karetova, D, Hajek, M, Linhart, A

Volltext

Right ventricular involvement in Fabry disease von Dostalova, G, Palecek, T, Kuchynka, P, Karetova, D, Bultas, J, Linhart, A

Volltext

Cardiac and Vascular Hypertrophy in Fabry Disease: Evidence for a New Mechanism Independent of Blood Pressure and Glycosphingolipid Deposition von Barbey, Frédéric, Brakch, Noureddine, Linhart, Aleš, Rosenblatt-Velin, Nathalie, Jeanrenaud, Xavier, Qanadli, Salah, Steinmann, Beat, Burnier, Michel, Palecek, Tomas, Bultas, Jan, Hayoz, Daniel

Volltext

Relationship between X-inactivation and clinical involvement in fabry heterozygotes. Eleven novel mutations in the α-galactosidase A gene in the Czech and Slovak population von DOBROVOLNY, Robert, DVORAKOVA, Lenka, LEDVINOVA, Jana, MAGAGE, Sudheera, BULTAS, Jan, LUBANDA, Jean C, ELLEDER, Milan, KARETOVA, Debora, PAVLIKOVA, Marketa, HREBICEK, Martin

Volltext

Potent anti-ischaemic effects of statins in chronic stable angina: incremental benefit beyond lipid lowering? von Deanfield, John E., Sellier, Phillipe, Thaulow, Erik, Bultas, Jan, Yunis, Carla, Shi, Harry, Buch, Jan, Beckerman, Bruce

Volltext

Fabry disease: Guidelines for the evaluation and management of multi-organ system involvement von Eng, Christine M., Germain, Dominique P., Banikazemi, Maryam, Warnock, David G., Wanner, Christoph, Hopkin, Robert J., Bultas, Jan, Lee, Philip, Sims, Katherine, Brodie, Scott E., Pastores, Gregory M., Strotmann, Joerg M., Wilcox, William R.

Volltext

Clinical benefits of early treatment with Fabrazyme in Fabry disease von Waldek, S, Banikazemi, M, Bultas, J, Wilcox, W, Whitley, C, McDonald, M, Finke, R, Packman, S, Bichet, D, Warnock, D, Brenner, B, Desnick, R

Volltext

Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: Results of the CAP (Comparative Atorv... von Bonnet, Jacques, MD, McPherson, R., MD PhD, Tedgui, A., MD, Simoneau, D., MD, Nozza, A., MSc, Martineau, P., PharmD, Davignon, Jean, MD

Volltext